Activation of the cAMP-dependent signaling pathway downregulates the expression of interleukin-3 and granulocyte-macrophage colony-stimulating factor in activated human T lymphocytes
- PMID: 8641331
Activation of the cAMP-dependent signaling pathway downregulates the expression of interleukin-3 and granulocyte-macrophage colony-stimulating factor in activated human T lymphocytes
Abstract
Expression of cytokines by T lymphocytes is a highly balanced process, involving stimulatory and inhibitory intracellular signaling pathways. We have examined the modulating effects of the cAMP-dependent signaling pathway on the expression of interleukin-3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF) in activated human T lymphocytes. 2'-O-dibutyryl-cAMP (db-cAMP), prostaglandin E2 (PGE2), isoproterenol (ISO), and isobutyl-methyl-xantin (IBMX) costimulated with concanavalin A (Con A) or Con A plus the phorbolester phorbol myristate acetate (PMA) inhibited IL-3 and GM-CSF mRNA accumulation compared to the effects of Con A or Con A plus PMA alone. Nuclear run-on experiments revealed that the inhibitory effect of db-cAMP could partially be ascribed to a five-fold reduction in transcription rate of both the IL-3 and GM-CSF gene in the presence of Con A or Con A plus PMA. mRNA stability studies demonstrated that PMA increased the stability of both transcripts. db-cAMP did not affect the stability of IL-3 and GM-CSF mRNAs in Con A activated cells. In contrast, in Con A plus PMA activated cells, db-cAMP significantly reduced the half-life of both transcripts: IL-3 >240 minutes vs. 90 minutes and GM-CSF 90 minutes vs. 60 minutes. Finally, in accordance with the mRNA data, db-cAMP, PGE2, and ISO reduced the secretion of IL-3 and GM-CSF protein in Con A and Con A plus PMA activated cells. In conclusion, these data demonstrate that the protein kinase A (PKA)-dependent signaling pathway is an important regulatory mechanism in controlling IL-3 and GM-CSF gene expression in activated human T lymphocytes.
Similar articles
-
IL-7 enhances the expression of IL-3 and granulocyte-macrophage-CSF mRNA in activated human T cells by post-transcriptional mechanisms.J Immunol. 1993 Apr 1;150(7):2584-90. J Immunol. 1993. PMID: 8454845
-
Interleukin-4 gene expression in activated human T lymphocytes is regulated by the cyclic adenosine monophosphate-dependent signaling pathway.Blood. 1996 Jan 15;87(2):691-8. Blood. 1996. PMID: 8555492
-
Granulocyte-macrophage colony-stimulating factor expression is regulated at transcriptional and posttranscriptional levels in a murine bone marrow stromal cell line.Exp Hematol. 1994 Aug;22(9):924-32. Exp Hematol. 1994. PMID: 8062890
-
Regulation of granulocyte-macrophage colony-stimulating factor and interleukin 3 expression.Stem Cells. 1995 Jul;13(4):324-35. doi: 10.1002/stem.5530130402. Stem Cells. 1995. PMID: 7549890 Review.
-
Regulation of IL-3, IL-4 and GM-CSF genes and signal transduction by their receptors.Lymphokine Res. 1990 Winter;9(4):551-3. Lymphokine Res. 1990. PMID: 2151048 Review. No abstract available.
Cited by
-
cAMP attenuates interleukin-1-stimulated macrophage colony-stimulating factor (M-CSF) expression.Biochem J. 2000 Aug 15;350 Pt 1(Pt 1):115-22. Biochem J. 2000. PMID: 10926834 Free PMC article.
-
Genome-wide analysis of mRNA decay in resting and activated primary human T lymphocytes.Nucleic Acids Res. 2002 Dec 15;30(24):5529-38. doi: 10.1093/nar/gkf682. Nucleic Acids Res. 2002. PMID: 12490721 Free PMC article.
-
Elevated cyclic AMP suppresses ConA-induced MT1-MMP expression in MDA-MB-231 human breast cancer cells.Clin Exp Metastasis. 1998 Feb;16(2):185-91. doi: 10.1023/a:1006580406314. Clin Exp Metastasis. 1998. PMID: 9514100
-
Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture.J Clin Invest. 2000 Mar;105(6):823-32. doi: 10.1172/JCI8195. J Clin Invest. 2000. PMID: 10727451 Free PMC article.
-
Suppression of granulocyte/macrophage colony-stimulating factor release from human monocytes by cyclic AMP-elevating drugs: role of interleukin-10.Br J Pharmacol. 2001 Sep;134(1):58-67. doi: 10.1038/sj.bjp.0704238. Br J Pharmacol. 2001. PMID: 11522597 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous